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Series or parallel? This is the most basic question that can be 
asked about a circuit, whether electrical or biological. The   
ESCRT protein complexes sort ubiquitinated transmembrane pro-
teins into multivesicular bodies (MVBs). MVBs are intermedi-
ate  structures  in  the  endosomal–lysosomal  pathway  that  are 
formed when portions of the endosomal limiting membrane bud 
into the lumen of the endosome, forming intralumenal vesicles 
(ILVs). The  ESCRT  machinery  consists  of  five  multiprotein 
complexes, ESCRT-0, -I, -II, -III, and Vps4–Vta1 (Saksena 
et al., 2007; Williams and Urbe, 2007; Hurley, 2008), along with 
several associated proteins. ESCRT-III carries out the scission 
of the ILVs from the limiting membrane, and the Vps4–Vta1 com-
plex recycles ESCRT-III (Wollert et al., 2009). Thus, ESCRT-III 
and Vps4–Vta1 act in series with respect to each other, and   
both act downstream of the other components. Early models   
of  ESCRT  function  suggested  that  the  upstream  complexes   
ESCRT-0 through -II also functioned in series, perhaps handing 
off ubiquitinated cargo from one complex to another in a sort of 
bucket brigade. However, biological circuits, just like electrical 
ones, can also act in parallel. In fact, recent evidence indicates 
that upstream ESCRT complexes act in parallel. In this model, 
the upstream ESCRTs form a supercomplex that clusters ubiq-
uitinated cargo in preparation for its internalization (Hurley, 
2008). Now, new work from Shields et al. (see p. 213 of this   
issue) provides some of the most compelling evidence yet that 
the upstream ESCRTs work together in parallel.
The resistance of a series of resistors in a direct current cir-
cuit is the direct sum of the resistances of the individual resistors. 
The endosomal sorting complex required for transport 
(ESCRT) complexes sort ubiquitinated membrane proteins 
into multivesicular bodies, which is a key step in the lyso-
somal degradation pathway. Shields et al. (Shields, S.B., 
A.J. Oestreich, S. Winistorfer, D. Nguyen, J.A. Payne, 
D.J.  Katzmann,  and  R.  Piper.  2009.  J.  Cell  Biol. 
185:213–224)  identify  a  new  ubiquitin-binding  site   
in  ESCRT-I  and  provide  evidence  that  the  upstream   
ESCRT-I and -II complexes sort cargo in parallel rather 
than in series.
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In contrast, the resistance of a set of resistors in parallel is 
obtained from the reciprocal of the sum of the reciprocals   
of the individual resistors. A high resistance placed in series 
impedes the current through the entire circuit, whereas a high 
resistance in a parallel circuit has little effect, causing the cur-
rent to bypass it through lower resistances. Shields et al. (2009) 
applied this principle (although they do not frame it as such) 
to the flux of ubiquitinated cargo through the upstream portion 
of the ESCRT system. By using crystal and nuclear magnetic 
resonance structures of ESCRT ubiquitin-binding domains in 
complex with ubiquitin, they were able to generate mutant   
ESCRT complexes selectively crippled in individual ubiqui-
tin-binding domains. In the course of the study, they deduced 
the presence of a ubiquitin-binding domain at the C terminus 
of the ESCRT-I subunit Mvb12. The Mvb12 ubiquitin-binding 
domain consists of a short stretch of residues that are dis-
ordered, at least in the ESCRT-I tetramer structure, and does 
not conform to any established ubiquitin-binding motif. This 
discovery highlights how much there is still to be learned about 
ubiquitin-binding motifs and how many as yet undetected 
motifs might exist.
Crippling the ubiquitin interaction with the only known 
ubiquitin-binding domain, the second zinc finger (NZF2), in yeast 
ESCRT-II had essentially no phenotype. Sorting was maintained 
even when one of the ubiquitin-binding sites in ESCRT-I, the 
ubiquitin E2 variant (UEV) domain of the Vps23 subunit, was 
inactivated. Inactivation of the novel ESCRT-I ubiquitin-binding 
site in Mvb12 had no phenotype on its own. However, the simul-
taneous inactivation of all three sites blocked the sorting of most, 
although not all, cargoes tested. The ESCRT pathway is com-
plex, and a variety of explanations for the cooperative behavior 
of the ubiquitin-binding domains can be put forward. However, 
given what we know from biochemical, structural, and other 
genetic studies (Saksena et al., 2007; Williams and Urbe, 2007; 
Hurley, 2008), the most reasonable deduction is that ESCRT-I 
and -II work in parallel with respect to the equivalent of an elec-
trical current in this system, the flux of ubiquitinated cargo.
The new study also sheds light on the mechanisms ESCRT-I 
uses to bind ubiquitinated cargo. In both yeast and animals, the 
N-terminal UEV domain of the Vps23 subunit binds to a single 
ubiquitin moiety (Katzmann et al., 2001; Sundquist et al., 2004). 
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an ESCRT-I–II supercomplex as well as evidence for at least a 
transient ESCRT-0–I interaction. It is plausible, although cur-
rently unproven, that all three could simultaneously assemble 
into a physical complex (Fig. 1, left). The membrane surface 
area covered by a modeled 1:1:1 supercomplex of ESCRT-0,   
-I, and -II is of the correct magnitude to give rise to a single 
ILV in yeast (Hurley, 2008). In animal cells, ILVs are larger, 
and the supercomplex would need to have more than one copy 
of each individual complex (or there could be several copies of 
a 1:1:1 supercomplex). In this model, the supercomplex would 
fill the role that in more conventional vesicle trafficking sys-
tems is served collectively by coat and cargo adaptor proteins 
(Bonifacino and Glick, 2004). Current schemes envisage that 
the supercomplex, via ESCRT-II, would initiate the recruit-
ment and assembly of ESCRT-III (Fig. 1, middle; Saksena   
et al., 2009). As yet unknown factors, which could perhaps in-
clude deubiquitinating enzymes, would then trigger the release 
of the supercomplex from the membrane, leading to the clo-
sure of the ESCRT-III array and scission of cargo-containing 
vesicles into the lumen of the endosome (Fig. 1, right). The 
budding away from the cytosol that occurs in the MVB path-
way is distinct from other vesicular trafficking pathways in 
cells and thus requires mechanisms that have little precedent 
in conventional pathways. The synthesis of genetics, biochem-
istry, and structural analysis in the field, which the work of 
Shields et al. (2009) exemplifies in miniature, is finally lead-
ing to the outlines of a plausible mechanism for this most un-
usual sorting pathway.
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A second ubiquitin-binding site is now revealed at the C ter-
minus of the Mvb12 subunit of yeast ESCRT-I. This places the 
two ubiquitin-binding domains in close proximity to each other 
in three dimensions (Kostelansky et al., 2007). The human 
MVB12A and B isoforms are very divergent in sequence   
from yeast Mvb12, and it is not clear whether they bind ubiq-
uitin or not. However, the VPS37A subunit of human ESCRT-I 
contains a ubiquitin-binding domain at its N terminus (Williams, 
R.L., personal communication), which is in close spatial prox-
imity to the other ESCRT-I–binding sites. This is also true of 
the ubiquitin-binding sites on the subunits of the ESCRT-0 
complex (Hirano et al., 2006; Ren et al., 2009). Seeing these 
sites so close together highlights another longstanding issue in 
the ESCRT and ubiquitin-dependent sorting field: what is the 
nature of the ubiquitin modification that signals entry into the 
ESCRT pathway? Early work suggested that monoubiquitin 
was the key signal, but more recent data suggest that Lys-63 
(K63)–linked polyubiquitin may be the predominant signal. 
Some 50% of the ubiquitin on the EGF receptor, the best studied 
ESCRT substrate in human cells, is in the form of a K63-
linked polymer (Huang et al., 2006). In yeast, both the cell 
surface transporter Gap1 and the vacuolar hydrolase Cps1 require 
K63-linked polyubiquitination for entry into MVBs (Andre, 
B., personal communication). The occurrence of two ubiquitin-
binding sites in close spatial proximity in both the Hrs and 
STAM subunits of ESCRT-0 and in ESCRT-I suggests a mech-
anism for recognition of the K63 polyubiquitin chain. It also 
raises the question as to whether ESCRT-II, which is now the 
only upstream complex to contain only one known ubiquitin-
binding domain, contains additional as yet unidentified ubiquitin-
binding sites.
How might the concept of a parallel circuit for a ubiqui-
tinated cargo “current” translate into a biochemical mechanism? 
Yeast ESCRT-I and -II form a high-affinity supercomplex of 
1:1 stoichiometry (Gill et al., 2007) that coassembles in vitro 
on model membranes (Kostelansky et al., 2007). ESCRT-0 
and -I also physically interact, although work in our labora-
tory indicates that the binding is far weaker than for ESCRT-
I–II (unpublished data), and Shields et al. (2009) find that the 
putative ESCRT-I–binding site on ESCRT-0 is not required for 
function. Thus, there is strong physical evidence in support of 
Figure 1.  Budding into the endosome. A putative supercomplex of the ubiquitin-binding complexes ESCRT-0, -I, and -II may recruit and activate the mem-
brane scission complex ESCRT-III to promote the formation of ILVs in the endosome. DUB, deubiquitinating enzyme.187 CIRCUITRY OF CARGO FLUX IN THE ESCRT PATHWAY • Hurley and Ren
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